Intranasal immunization with inactivated feline calicivirus particles confers robust protection against homologous virus and suppression against heterologous virus in cats

Delivery of antigen to nasal-associated lymphoid tissue microfold cells through secretory IgA targeting local dendritic cells confers protective immunity

(2016) Nicolas Rochereau et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

European molecular epidemiology and strain diversity of feline calicivirus

(2016) J. Hou et al.   VETERINARY RECORD

Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells

(2015) Nicolas Rochereau et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Advances and challenges in mucosal adjuvant technology

(2015) Daniel Newsted et al.   VACCINE

Virulent feline calicivirus disease in a shelter in italy: A case description

(2013) Mara Battilani et al.   RESEARCH IN VETERINARY SCIENCE

Dectin-1 Is Essential for Reverse Transcytosis of Glycosylated SIgA-Antigen Complexes by Intestinal M Cells

(2013) Nicolas Rochereau et al.   PLOS BIOLOGY

New insights in mucosal vaccine development

(2011) Vincent Pavot et al.   VACCINE

Dealing with a potential case of FCV-associated virulent systemic disease

(2011) A. D. Radford et al.   VETERINARY RECORD

Immunological and Genetic Characterization of Feline Caliciviruses Used in the Development of a New Trivalent Inactivated Vaccine in Japan

(2010) Katsuo MASUBUCHI et al.   JOURNAL OF VETERINARY MEDICAL SCIENCE

A Nosocomial Outbreak of Feline Calicivirus Associated Virulent Systemic Disease in France

(2009) Brice S. Reynolds et al.   JOURNAL OF FELINE MEDICINE AND SURGERY

Efficacy of a bivalent inactivated non-adjuvanted feline calicivirus vaccine: Relation between in vitro cross-neutralization and heterologous protection in vivo

(2008) H. Poulet et al.   VACCINE

Comparison of the ability of feline calicivirus (FCV) vaccines to neutralise a panel of current UK FCV isolates

(2007) Carol J. Porter et al.   JOURNAL OF FELINE MEDICINE AND SURGERY